Thioredoxin (TRX)-interacting protein (TXNIP), a protein linked to NLRP3 inflammasome activation, is responsible for insulin resistance and is targeted too by novel therapeutic molecules in clinical trials [49]. Here, NLRP3 is linked to Insulin resistance.